{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:16:51Z","timestamp":1793038611559,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD100015"],"award-info":[{"award-number":["HD100015"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hypoglycemia and impaired metabolic transition are frequently observed in neonates during the first 24\u201348\u00a0h after birth [1, 2]. Severe (&lt;\u200936\u00a0mg\/dL or 2\u00a0mmol\/L) and recurrent (3 or more episodes) hypoglycemia can cause neurological injury and developmental delays. The ambiguity regarding a threshold blood glucose concentration remains due to differing values proposed by various professional organizations. This poses a challenge in diagnosing neonatal hypoglycemia in addition to using a single blood glucose value, which in itself is not entirely reflective of various key molecular processes uncovered by in vitro or pre-clinical studies. The symptoms of hypoglycemia can also be present in conditions other than hypoglycemia, e.g., sepsis and polycythemia, and in many cases, hypoglycemia is clinically unrecognized. Therefore, early screening of at-risk and otherwise healthy-appearing neonates is essential. Continuous glucose monitoring and early interventions such as glucose gel, breast and formula feeding, and intravenous glucose administration are utilized to prevent long-term neurological impairments. However, the safe limits of serum glucose that will prevent neuroglycopenia and neural injury are elusive. The impact of early screening and available therapies on neurodevelopmental outcomes remains uncertain due to the absence of a robust clinical design and combining all causes of neonatal hypoglycemia without making further distinctions from other conditions. This review highlights the controversies in definitions and the most recent information on long-term neurodevelopmental outcomes that may impact the early management of NH.<\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    : Optimizing the definitions and treatment of neonatal dysglycemia is crucial for\u00a0preventing hypoglycemia-related brain injury. Continuous glucose monitoring technology in neonates\u00a0offers a promising approach for real-time screening and early intervention.\u00a0\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              \u2022\u00a0\n                              <jats:italic>There is ongoing debate regarding the optimal glucose threshold for intervention and prevention of\u00a0<\/jats:italic>\n                              <jats:italic>hypoglycemia-induced brain injury.\u00a0This suggests brain injury may be incurred over a range rather than a single blood glucose concentration.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              <jats:italic>\u2022\u00a0Recent studies suggest that glucose concentrations between 36 mg\/dL (2 mmol\/L) and 47 mg\/dL (2.6 mmol\/L)\u00a0are acceptable in asymptomatic neonates. However, neurological injury was observed in early school age with\u00a0glucose values of &lt;36 mg\/dl (&lt;2 mmol\/L) and in mid-childhood of &lt;30-36 mg\/dL (&lt;1.7 -2 mmol\/L). This suggests\u00a0brain injury may be incurred over a range rather than a single blood glucose concentration.<\/jats:italic>\n                              <jats:italic>\u2022\u00a0Continuous glucose monitoring (CGM) highlights real-time glucose measurement and glycemic lability in neonates.\u00a0<\/jats:italic>\n                              <jats:italic>Its use may mitigate long-term neurologic injury by improving early recognition and treatment.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-025-06082-z","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T22:46:30Z","timestamp":1742683590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Exploring the long-term impacts of neonatal hypoglycemia to determine a safe threshold for glucose concentrations"],"prefix":"10.1007","volume":"184","author":[{"given":"Meena","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7313-1189","authenticated-orcid":false,"given":"Sherin U.","family":"Devaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"6082_CR1","doi-asserted-by":"publisher","first-page":"1179102","DOI":"10.3389\/fendo.2023.1179102","volume":"14","author":"M Roeper","year":"2023","unstructured":"Roeper M, Hoermann H, Kummer S, Meissner T (2023) Neonatal hypoglycemia: lack of evidence for a safe management. Front Endocrinol (Lausanne). 14:1179102. https:\/\/doi.org\/10.3389\/fendo.2023.1179102","journal-title":"Front Endocrinol (Lausanne)."},{"key":"6082_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpeds.2020.02.079","volume":"223","author":"DL Harris","year":"2020","unstructured":"Harris DL, Weston PJ, Gamble GD, Harding JE (2020) Glucose profiles in healthy term infants in the first 5 days: the Glucose in Well Babies (GLOW) study. J Pediatr. 223:34-41e4. https:\/\/doi.org\/10.1016\/j.jpeds.2020.02.079","journal-title":"J Pediatr."},{"issue":"1","key":"6082_CR3","doi-asserted-by":"publisher","first-page":"e000544","DOI":"10.1136\/bmjmed-2023-000544","volume":"3","author":"JE Harding","year":"2024","unstructured":"Harding JE, Alsweiler JM, Edwards TE, McKinlay CJ (2024) Neonatal hypoglycaemia. BMJ Med 3(1):e000544. https:\/\/doi.org\/10.1136\/bmjmed-2023-000544","journal-title":"BMJ Med"},{"key":"6082_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jpeds.2022.02.045","volume":"245","author":"H Hoermann","year":"2022","unstructured":"Hoermann H, Mokwa A, Roeper M, SalimiDafsari R, Koestner F, Hagenbeck C, Mayatepek E, Kummer S, Meissner T (2022) Reliability and observer dependence of signs of neonatal hypoglycemia. J Pediatr. 245:22\u20139 e2. https:\/\/doi.org\/10.1016\/j.jpeds.2022.02.045","journal-title":"J Pediatr."},{"issue":"6659","key":"6082_CR5","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/bmj.297.6659.1304","volume":"297","author":"A Lucas","year":"1988","unstructured":"Lucas A, Morley R, Cole TJ (1988) Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ. 297(6659):1304\u20138. https:\/\/doi.org\/10.1136\/bmj.297.6659.1304","journal-title":"BMJ."},{"issue":"5","key":"6082_CR6","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1542\/peds.105.5.1141","volume":"105","author":"M Cornblath","year":"2000","unstructured":"Cornblath M, Hawdon JM, Williams AF, Aynsley-Green A, Ward-Platt MP, Schwartz R, Kalhan SC (2000) Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics. 105(5):1141\u20135. https:\/\/doi.org\/10.1542\/peds.105.5.1141","journal-title":"Pediatrics."},{"issue":"1","key":"6082_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cen.14995","volume":"100","author":"K Luo","year":"2024","unstructured":"Luo K, Tang J, Zhang M, He Y (2024) Systematic review of guidelines on neonatal hypoglycemia. Clin Endocrinol (Oxf). 100(1):36\u201349. https:\/\/doi.org\/10.1111\/cen.14995","journal-title":"Clin Endocrinol (Oxf)."},{"key":"6082_CR8","doi-asserted-by":"publisher","first-page":"1115228","DOI":"10.3389\/fped.2023.1115228","volume":"11","author":"MS Kalogeropoulou","year":"2023","unstructured":"Kalogeropoulou MS, Iglesias-Platas I, Beardsall K (2023) Should continuous glucose monitoring be used to manage neonates at risk of hypoglycaemia? Front Pediatr. 11:1115228. https:\/\/doi.org\/10.3389\/fped.2023.1115228","journal-title":"Front Pediatr."},{"issue":"6","key":"6082_CR9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1056\/NEJMoa1905593","volume":"382","author":"A van Kempen","year":"2020","unstructured":"van Kempen A, Eskes PF, Nuytemans D, van der Lee JH, Dijksman LM, van Veenendaal NR, van der Hulst F, Moonen RMJ, Zimmermann LJI, van\u2019t Verlaat EP, van Dongen-van Baal M, Semmekrot BA, Stas HG, van Beek RHT, Vlietman JJ, Dijk PH, Termote JUM, de Jonge RCJ, de Mol AC, Huysman MWA, Kok JH, Offringa M, Boluyt N, Hypo ESG (2020) Lower versus traditional treatment threshold for neonatal hypoglycemia. N Engl J Med. 382(6):534\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1905593","journal-title":"N Engl J Med."},{"key":"6082_CR10","doi-asserted-by":"publisher","first-page":"1147659","DOI":"10.3389\/fped.2023.1147659","volume":"11","author":"DL Harris","year":"2023","unstructured":"Harris DL, Weston PJ, Harding JE (2023) Relationships between feeding and glucose concentrations in healthy term infants during the first five days after birth-the Glucose in Well Babies study (GLOW). Front Pediatr. 11:1147659. https:\/\/doi.org\/10.3389\/fped.2023.1147659","journal-title":"Front Pediatr."},{"issue":"3","key":"6082_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/archdischild-2020-320305","volume":"106","author":"R Griffith","year":"2021","unstructured":"Griffith R, Hegarty JE, Alsweiler JM, Gamble GD, May R, McKinlay CJD, Thompson B, Wouldes TA, Harding JE (2021) Two-year outcomes after dextrose gel prophylaxis for neonatal hypoglycaemia. Arch Dis Child Fetal Neonatal Ed. 106(3):278\u201385. https:\/\/doi.org\/10.1136\/archdischild-2020-320305","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"issue":"11","key":"6082_CR12","doi-asserted-by":"publisher","first-page":"CD012152","DOI":"10.1002\/14651858.CD012152.pub4","volume":"11","author":"L Roberts","year":"2023","unstructured":"Roberts L, Lin L, Alsweiler J, Edwards T, Liu G, Harding JE (2023) Oral dextrose gel to prevent hypoglycaemia in at-risk neonates. Cochrane Database Syst Rev. 11(11):CD012152. https:\/\/doi.org\/10.1002\/14651858.CD012152.pub4","journal-title":"Cochrane Database Syst Rev."},{"key":"6082_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jpeds.2017.06.034","volume":"190","author":"DL Harris","year":"2017","unstructured":"Harris DL, Gamble GD, Weston PJ, Harding JE (2017) What happens to blood glucose concentrations after oral treatment for neonatal hypoglycemia? J Pediatr. 190:136\u201341. https:\/\/doi.org\/10.1016\/j.jpeds.2017.06.034","journal-title":"J Pediatr."},{"issue":"9910","key":"6082_CR14","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(13)61645-1","volume":"382","author":"DL Harris","year":"2013","unstructured":"Harris DL, Weston PJ, Signal M, Chase JG, Harding JE (2013) Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial. Lancet. 382(9910):2077\u201383. https:\/\/doi.org\/10.1016\/S0140-6736(13)61645-1","journal-title":"Lancet."},{"issue":"1","key":"6082_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.yapd.2024.03.001","volume":"71","author":"CA Stanley","year":"2024","unstructured":"Stanley CA, De Leon DD (2024) Etiology of the neonatal hypoglycemias. Adv Pediatr. 71(1):119\u201334. https:\/\/doi.org\/10.1016\/j.yapd.2024.03.001","journal-title":"Adv Pediatr."},{"issue":"6","key":"6082_CR16","doi-asserted-by":"publisher","first-page":"e2415764","DOI":"10.1001\/jamanetworkopen.2024.15764","volume":"7","author":"D Laing","year":"2024","unstructured":"Laing D, Walsh EPG, Alsweiler JM, Hanning SM, Meyer MP, Ardern J, Cutfield WS, Rogers J, Gamble GD, Chase JG, Harding JE, McKinlay CJD (2024) Diazoxide for severe or recurrent neonatal hypoglycemia: a randomized clinical trial. JAMA Netw Open. 7(6):e2415764. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.15764","journal-title":"JAMA Netw Open."},{"key":"6082_CR17","doi-asserted-by":"publisher","first-page":"634305","DOI":"10.3389\/fendo.2021.634305","volume":"12","author":"LC De Angelis","year":"2021","unstructured":"De Angelis LC, Brigati G, Polleri G, Malova M, Parodi A, Minghetti D, Rossi A, Massirio P, Traggiai C, Maghnie M, Ramenghi LA (2021) Neonatal hypoglycemia and brain vulnerability. Front Endocrinol (Lausanne) 12:634305. https:\/\/doi.org\/10.3389\/fendo.2021.634305","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"6082_CR18","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1172\/JCI30077","volume":"117","author":"SW Suh","year":"2007","unstructured":"Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA (2007) Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest. 117(4):910\u20138. https:\/\/doi.org\/10.1172\/JCI30077","journal-title":"J Clin Invest."},{"key":"6082_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jpeds.2020.12.063","volume":"231","author":"DL Harris","year":"2021","unstructured":"Harris DL, Weston PJ, Harding JE (2021) Alternative cerebral fuels in the first five days in healthy term infants: the Glucose in Well Babies (GLOW) study. J Pediatr. 231:81\u20136 e2. https:\/\/doi.org\/10.1016\/j.jpeds.2020.12.063","journal-title":"J Pediatr."},{"issue":"16","key":"6082_CR20","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1504909","volume":"373","author":"CJ McKinlay","year":"2015","unstructured":"McKinlay CJ, Alsweiler JM, Ansell JM, Anstice NS, Chase JG, Gamble GD, Harris DL, Jacobs RJ, Jiang Y, Paudel N, Signal M, Thompson B, Wouldes TA, Yu TY, Harding JE, Group CS (2015) Neonatal glycemia and neurodevelopmental outcomes at 2 years. N Engl J Med 373(16):1507\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1504909","journal-title":"N Engl J Med"},{"issue":"10","key":"6082_CR21","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jamapediatrics.2017.1579","volume":"171","author":"CJD McKinlay","year":"2017","unstructured":"McKinlay CJD, Alsweiler JM, Anstice NS, Burakevych N, Chakraborty A, Chase JG, Gamble GD, Harris DL, Jacobs RJ, Jiang Y, Paudel N, San Diego RJ, Thompson B, Wouldes TA, Harding JE, Children with H, their later development study TChildren with H, their later development study T (2017) Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years. JAMA Pediatr 171(10):972\u201383. https:\/\/doi.org\/10.1001\/jamapediatrics.2017.1579","journal-title":"JAMA Pediatr"},{"issue":"3","key":"6082_CR22","doi-asserted-by":"publisher","first-page":"e243683","DOI":"10.1001\/jamanetworkopen.2024.3683","volume":"7","author":"M Roeper","year":"2024","unstructured":"Roeper M, Hoermann H, Korner LM, Sobottka M, Mayatepek E, Kummer S, Meissner T (2024) Transitional neonatal hypoglycemia and adverse neurodevelopment in midchildhood. JAMA Netw Open. 7(3):e243683. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.3683","journal-title":"JAMA Netw Open."},{"key":"6082_CR23","doi-asserted-by":"publisher","first-page":"114119","DOI":"10.1016\/j.jpeds.2024.114119","volume":"272","author":"X Wei","year":"2024","unstructured":"Wei X, Franke N, Alsweiler JM, Brown GTL, Gamble GD, McNeill A, Rogers J, Thompson B, Turuwhenua J, Wouldes TA, Harding JE, McKinlay CJD, pre-h PODES-aOSG (2024) Neonatal hypoglycemia and neurocognitive function at school age: a prospective cohort study. J Pediatr. 272:114119. https:\/\/doi.org\/10.1016\/j.jpeds.2024.114119","journal-title":"J Pediatr."},{"issue":"12","key":"6082_CR24","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00431-020-03729-x","volume":"179","author":"AH Rasmussen","year":"2020","unstructured":"Rasmussen AH, Wehberg S, Portner F, Larsen AM, Filipsen K, Christesen HT (2020) Neurodevelopmental outcomes after moderate to severe neonatal hypoglycemia. Eur J Pediatr. 179(12):1981\u201391. https:\/\/doi.org\/10.1007\/s00431-020-03729-x","journal-title":"Eur J Pediatr."},{"issue":"10","key":"6082_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/jamapediatrics.2015.1631","volume":"169","author":"JR Kaiser","year":"2015","unstructured":"Kaiser JR, Bai S, Gibson N, Holland G, Lin TM, Swearingen CJ, Mehl JK, ElHassan NO (2015) Association between transient newborn hypoglycemia and fourth-grade achievement test proficiency: a population-based study. JAMA Pediatr. 169(10):913\u201321. https:\/\/doi.org\/10.1001\/jamapediatrics.2015.1631","journal-title":"JAMA Pediatr."}],"updated-by":[{"DOI":"10.1007\/s00431-026-06877-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000}}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06082-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:57:38Z","timestamp":1776923858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06082-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["6082"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06082-z","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to a dosage error identified on page 5.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00431-026-06877-8","URL":"https:\/\/doi.org\/10.1007\/s00431-026-06877-8","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No original research is presented in this review; thus, the Approval Committee and Internal Review Board (IRB) are not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"263"}}